National Health (Continued Dispensing – Emergency Measures) Amendment Determination 2021 (No. 10) (Cth)

PB 112 of 2021

National Health (Continued Dispensing – Emergency Measures) Amendment Determination 2021 (No. 10)

I, NIKOLAI TSYGANOV, Assistant Secretary (Acting), Pricing and PBS Policy Branch, Technology Assessment and Access Division, Department of Health, and delegate of the Minister for Health and Aged Care, make the following determination.

Dated               28 October 2021

NIKOLAI TSYGANOV

Assistant Secretary (Acting)

Pricing and PBS Policy Branch

Technology Assessment and Access Division

Department of Health

Contents

1           Name…………………………………………………………………………….………………1

2.......... Commencement............................................................................................................................ 1

3.......... Authority...................................................................................................................................... 1

4 ......... Schedule....................................................................................................................................... 1

Schedule 1—Amendments   2

National Health (Continued Dispensing - Emergency Measures) Determination 2020         2

1        Name

(1)This instrument is the National Health (Continued Dispensing – Emergency Measures) Amendment Determination 2021 (No. 10).

(2)This instrument may also be cited as PB 112 of 2021.

2        Commencement

(1)Each provision of this instrument specified in column 1 of the table commences, or is taken to have commenced, in accordance with column 2 of the table. Any other statement in column 2 has effect according to its terms.

Commencement information
Column 1	Column 2	Column 3
Provisions	Commencement	Date/Details
1.  The whole of this instrument	1 November 2021	1 November 2021

Note:          This table relates only to the provisions of this instrument as originally made. It will not be amended to deal with any later amendments of this instrument.

(2)Any information in column 3 of the table is not part of this instrument. Information may be inserted in this column, or information in it may be edited, in any published version of this instrument.

1. Authority

This instrument is made under subsection 89A(3) of the National Health Act 1953.

4        Schedules

Each instrument that is specified in a Schedule to this instrument is amended or repealed as set out in the applicable items in the Schedule concerned, and any other item in a Schedule to this instrument has effect according to its terms.

Schedule 1—Amendments

National Health (Continued Dispensing – Emergency Measures) Determination 2020

1. Schedule 1, after entry for Budesonide with formoterol in the form Pressurised inhalation containing budesonide 50 micrograms with formoterol fumarate dihydrate 3 micrograms per dose, 120 doses

insert:

Budesonide with glycopyrronium and formoterol Pressurised inhalation containing budesonide 160 micrograms with glycopyrronium 7.2 micrograms and formoterol fumarate dihydrate 5 micrograms per dose, 120 doses Inhalation by mouth

1. Schedule 1, entry for Calcipotriol with betamethasone

omit:

Gel containing calcipotriol 50 micrograms with betamethasone 500 micrograms (as dipropionate) per g,
60 g Application

1. Schedule 1, after entry for Dapsone in the form Tablet 25 mg

insert:

Daratumumab	Solution for subcutaneous injection containing daratumumab 1800 mg in 15 mL	Injection
Darolutamide	Tablet 300 mg	Oral

1. Schedule 1, entry for Pindolol

omit:

Tablet 5 mg (USP) Oral